Linzagolix choline
N/A
Report date: 2026/05/02 20:00:18
NME
Base Information
Drug NameLinzagolix choline
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[11]
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2022/06/14
Country/Territory +[19]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesKissei Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesJw Pharmaceutical CorpTheramex Ireland LtdSynmosa Biopharma Corp +[7]
Inactive CompaniesObseva Ireland LtdObseva Sa
Active Indications +[9]
Inactive Indications